A method for identifying the enantiomers of N,O-di-trifluoroacetylated ephedrine (EP) and norephedrine (NE) and the enantiomers of pseudoephedrine (PEP) and pseudonorephedrine (PNE) in plasma was developed using chiral capillary gas chromatography -mass spectrometry (GC-MS) with selected ion monitoring (SIM). N,O-Ditrifluoroacethyl (TFA) derivatization was accomplished in a dried hydrochloride extract of plasma (minimum quantity of 0.2 mL). An SIM GC-MS method with a b-cyclodextrin chiral capillary column allowed the successful and simultaneous detection of each TFAderivatized stereoisomer of EP, NE, PEP, PNE, and an internal standard (IS; S-(1)-ethylamphetamine). Each TFA-drivatized stereoisomer was identified using four mass fragment ions (m/z 140, 154, 168, and 230). The TFA-derivatized stereoisomers of EP, NE, PEP, PNE, and IS were separated completely and were detected with sufficient sensitivity. The assay allowed the stereoisomers to be determined in a linear range of 12.5 -1250 ng/mL for the EP stereoisomers and a linear range of 5 -1250 ng/mL for the PEP, NE, and PNE stereoisomers. The detection limits were 7.5 ng/mL for the EP stereoisomers and 2.5 ng/mL for the PEP, NE, and PNE stereoisomers. The intra-and interday precisions were less than 5.9% and 8.2%, respectively. This chiral capillary SIM GC-MS method was sufficiently effective in the analysis of plasma from users of over-the-counter cold medicines and was also fully applicable to the plasma analysis of guinea pigs following their treatment with racemic EP.
Introduction
Ephedrine (EP) is found in Chinese Ephedra (ma-huang) (1, 2) . It has two asymmetric carbons, and it therefore occurs as four stereoisomers. The four stereoisomers are the EP enantiomers and pseudoephedrine (PEP) enantiomers: the enantiomer of (1R,
2S) ( -)-EP [I] is (1S, 2R) (þ)-EP [II] and that of (1R, 2R) ( -)-PEP [III] is (1S, 2S) (þ)-PEP [IV]. The [I] and [II]
stereoisomers and the [III] and [IV] stereoisomers are also diastereomers. The four configurations of EP are the same for the stereoisomers of norephedrine (NE). A mixture of racemic EP and racemic PEP is produced during the chemical synthesis of EP (3) . Of the four stereoisomers of EP, the (1R, 2S)-( -)-EP and (1S, 2S)-(þ)-PEP are common constituents of cold medicines and are also found in various dietary supplements (4, 5) , herbal materials (6) , and unregulated drugs (7) , including those derived from Ephedra. The use of these pharmaceuticals has been associated with adverse cardiovascular events, including acute myocardial infarction, severe hypertension, myocarditis, and lethal cardiac arrhythmias (8) . For this reason, the sale of supplements containing Ephedra has been prohibited in some countries. EP is also used in some doping practices (9) , and its raw materials are used to synthesize the stimulant drug methamphetamine (MA) (10) . EP and/or NE are also metabolites of the anti-inflammatory drug famprofazone (11) and MA (12) .
Several methods have been used to analyze the stereoisomers of EP and NE, including gas chromatography (GC) (6, 13) , capillary electrophoresis (CE) (7, 14, 15) , high-performance liquid chromatography (15) , and mass spectrometry (MS) coupled to GC (16) or CE (17) . These methods have also been used to analyze EP and NE in dietary supplements (4, 5) , unregulated drugs (7) , and human urine (11) . Although the use of chiral derivatization or a chiral selector is usually required for the separation and detection of stereoisomers, the analysis of the NE and EP stereoisomers using chiral derivatization (16, 18) is particularly difficult because there are two functional groups in the structure (an amino group and a hydroxyl group). Furthermore, these methods have not yet been fully optimized for blood or plasma samples, partly because the level of the drug in the blood or plasma is generally lower than that in the urine. Blood also contains a number of matrices (e.g., proteins and blood cells), so that the sample must be cleaned carefully to detect the small amounts of target substances. This clean-up is as important as that used for urine samples. In the fields of clinical and forensic toxicology, the determination of drug levels in the blood or plasma is important in evaluating the effects and intoxicating doses of drugs.
Our goal was to develop a detection system for the enantiomers [(1R, 2S)-(-) forms and (1S, 2R)-(þ) forms] of EP and NE in the plasma, and a method for the simultaneous identification of the enantiomers [(1R, 2R)-(-) forms and (1S, 2S)-(þ) forms] of PEP and pseudonorephedrine (PNE) using a simple acylation process. We wanted to develop a sensitive analytical technique with which to identify the enantiomers and diastereomers of diluted EP and NE in the plasma that would allow their detection in small amounts of sample material. We report the separation and detection of the enantiomers and diastereomers of N, O-di-trifluoroacetylated EP and NE in plasma using chiral capillary GC-MS with selected ion monitoring (SIM).
pseudonorephedrine (PNE)-HCl in the (1R, 2R)-(-) form were supplied by Dr I. Yasuda (Tokyo Metropolitan Institute of Public Health, Tokyo, Japan). We purchased the following reagents: racemic EP-HCl of the erythro type from Iwaki Pharmaceutical (Tokyo, Japan); norephedrine (NE)-HCl in the (1R, 2S)-( -) form from Aldrich Chemical (Milwaukee, WI); NE-HCl in the (1S, 2R)-(þ) form and its racemate from Tokyo Kasei Industries, Co. (Tokyo, Japan); and PNE-HCl in the (1S, 2S)-(þ) form from Sigma (Tokyo, Japan). Trifluoroacetic anhydride was purchased from Tokyo Kasei Industries, Co. (S)-(þ)-Ethylamphetamine (EAM)-HCl was obtained by the optical resolution (19) of racemic EAM using (S)-(þ)-mandelic acid from Aldrich Chemical. b-Glucuronidase/arylsulfatase (EC 3.2.1.31) was purchased from Merck (Tokyo, Japan). Two over-the-counter (OTC) cold medicines were purchased: Ephedrine "Nagai"
w from Dainippon Pharmaceutical Co., Ltd. (Osaka, Japan) and Benza Block L w from Takeda Chemical Industries, Ltd. (Osaka, Japan). All other chemicals were obtained from commercial sources.
Sample preparation
Only EP [(1R, 2S)-( -) form] and PEP [(1S, 2S)-(þ) form] are currently approved as clinical medicines in Japan and can therefore be administered to humans. However, the use of racemic EP for humans is legally prohibited. Therefore, guinea pigs were used as the model organisms to test racemic EP because its major metabolites (EP and NE) found in human urine (20) are also detected in guinea pig urine (21) . The preparation of the human and guinea pig samples was as follows.
Human plasma. The Human Study Committee of Dokkyo Medical University School of Medicine approved this study, which was deemed to comply with the ethical code for human studies of the same institution. Before the blood was collected, a physician gave two healthy male volunteers full verbal and written explanations of the purpose and methods of the study. The subjects then gave their written consent to participate. Venous blood samples were obtained from their right arms after a single oral dose (50 mg/person) of an OTC cold medicine (Ephedrine "Nagai" or Benza Block L) containing 25 mg of EP-HCl or PEP-HCl, respectively, with water. Blood was collected 2 h after the medicine was taken. Human drug-free control blood was obtained from two healthy male volunteers. These blood samples were collected using a glass test tube containing heparin. After the blood samples were centrifuged at 1500 Â g for 15 min, the plasma samples were separated from them and stored at -20 8C until analysis.
Guinea pig plasma. Five male guinea pigs (Dunkin-Hartley strain, 327 -333 g) were purchased from the Shizuoka Laboratory Animal Center (Shizuoka, Japan). The Animal Study Committee of Dokkyo Medical University School of Medicine approved this study, which was deemed to comply with the ethical code for animal studies of the same institution. Three guinea pigs received an intravenous injection (1.0 mg/kg) of racemic EP-HCl dissolved in saline. Blood was collected from the cervical vein under urethane (ethyl carbamate) anesthesia (22) 2 h after the drug had been administered. Drug-free control blood was obtained from the other two guinea pigs. These blood samples were collected using a glass test tube containing heparin. After the blood samples were centrifuged at 1500 Â g for 15 min, the plasma samples were separated from them and stored at -208C until analysis.
Extraction procedure Plasma (200 mL) was hydrolyzed for 16 h at 378C with 1 M acetate buffer ( pH 5.5, 400 mL) and b-glucuronidase/arylsulfatase (15 mL) to hydrolyze the conjugates of EP and NE. The hydrolysates were further diluted to a volume of 0.75 mL with distilled water after the addition of 25 mL of (S)-(þ)-EAM (1000 ng/mL) as the internal standard (IS). The pH of this solution was adjusted to between 9.0 and 9.3 with a saturated aqueous solution of NaHCO 3 , after which the sample was loaded onto an Xtrelut w NT 1 column (Merck). EP, PEP, NE, and PNE were eluted from the column after 15 min with dichloromethane/2-propanol (88:12, v/v, 6 mL). They were then re-extracted with 0.01 M HCl (0.7 mL). The HCl extracts (0.6 mL) were dried for 20 -30 min at 558C (Dry ThermoUnit DTU-IC, Taitec, Tokyo, Japan) using nitrogen gas for subsequent trifluoroacetyl derivatization.
Trifluoroacetyl derivatization
The N,O-di-trifluoroacetyl (TFA) derivatization of EP and NE was performed with the method of Martin et al. (23) . The dried HCl extract was dissolved in acetonitrile/ethyl acetate (1:1 v/v, 200 mL) and trifluoroacetic anhydride (75 mL) and allowed to react for 40 min at 408C. After the sample was evaporated to dryness under nitrogen gas, the residue was dissolved in 1.0 mL of ethyl acetate. A 1-mL aliquot was used for the analysis.
Instrumentation and analytical conditions
The mass spectra (MS) of the four TFA-derivatized EP analogues (EP, NE, PEP, and PNE) were recorded on an Agilent Technologies (Santa Clara, CA) 5973N quadrupole mass selective detector coupled to an Agilent Technologies 6890N network GC system, using a DB-5ms capillary column (30 m Â 0.25-mm i.d., 0.25-mm film thickness, Agilent Technologies). The GC column temperature was raised from 508C to 3008C at a rate of 208C/min, and the interface temperature was maintained at 2608C. The ionization energy was set at 75 eV. The flow rate of helium gas was maintained at 1.0 mL/min. This Agilent instrument was used only for the MS analysis of the EP analogues.
The SIM analysis of each TFA-derivatized stereoisomer of EP, PEP, NE, PNE, and IS was performed on a JEOL (Tokyo, Japan) Automass II 150 GC-MS system equipped with a b-DEX 225 capillary column (30 m Â 0.25 mm, 0.25-mm film thickness, SUPELCO/Sigma-Aldrich, Bellefonte, PA) containing a b-cyclodextrin derivative. The stereoisomeric identification of the four EP analogues (EP, NE, PEP, and PNE) and IS in the plasma was based on the selection and retention times of the characteristic fragment ions (m/z 140, 154, 168, and 230) of authentic samples in the electron ionization (EI) mode. One identification criterion is that the characteristic fragment ions (m/z 140, 154, 168, and 230) are not detected in the drug-free control plasma samples. Each sample used for stereoisomer analysis was injected into the GC in the splitless mode. The column temperature was raised from 508C to 1508C at a rate of 38C/min and then held at 1508C for 4 min, after which the temperature was further increased to 2208C at a rate of 128C/ min. The temperature was then held at 2208C for 7 min for the simultaneous analysis of the stereoisomers, during which period the temperatures of the injection port, ion source, and interface were maintained at 220, 180, and 2308C, respectively. The ionization energy was set at 75 eV. The flow rate of helium gas was maintained at 1.0 mL/min. This JEOL instrument was used for the stereoisomeric detection and quantification of the EP analogues in the plasma samples by SIM chromatogram analysis.
Calibration curve and quantitation Calibration curves were constructed by plotting the peak-area ratios for the stereoisomers of the four EP analogues (EP, NE, PEP, and PNE) versus that of IS in 0.2 mL of human or guinea pig plasma, using five calibration points per curve (5, 25, 50, 625, and 1250 ng/mL plasma of each pure stereoisomer). These calibration curves were constructed from triplicate measurements at each concentration. The four EP analogues in the plasma were quantified using the calibration curve.
Analytical precision
The reproducibility of this method was determined using intraday and interday variability data for human plasma samples fortified with three different concentrations (25, 500, or 1250 ng/ mL in plasma) of each stereoisomer of EP, PEP, NE, and PNE. The intraday precision was calculated with five repeated analyses of human plasma samples spiked with the three different concentrations over a day. The interday precision was calculated by analyzing (once daily) the variations in the concentrations in the human plasma samples spiked with the three different concentrations over five days.
Results and Discussion
TFA derivatization of EP, NE, PEP, and PNE The structures of both EP and NE contain two functional groups, an amino group and a hydroxyl group. This is also true for PEP and PNE. The acylation of two functional groups (both the amino and hydroxyl groups) is more difficult than the acylation of a single amino group, as occurs in MA or amphetamine. According to Shin et al. (16, 18) , the acylation of these two functional groups requires the use of two different reagents, a protective agent, such as N-methyl-N-trimethylsilyl (TMS) or N-methyl-N-triethylsilyl trifluoroacetamide (TEA), for the hydroxyl group, and a chiral derivatization agent, such as (S)-( -)-a-methoxy-a-trifluoromethyl-phenylacetyl chloride (MTPA), for the amino group. The derivatives are then analyzed by SIM GC -MS using a standard achiral column (16, 18) . In contrast, our method does not require chiral derivatization when a b-cyclodextrin chiral column is used, although the acylation of the two functional groups is necessary for the stereoisomeric separation of EP, NE, PEP, and PNE. For these acylations (i.e., TFA derivatization), dried HCl extracts from the plasma samples were used and acylated using the method of Martin et al. (23) . The purpose of the HCl extraction is to further clean the organic extract, and the evaporation to dryness of the HCl extract is time consuming, taking about 20 min under nitrogen gas. TFA derivatization is relatively easy to perform in a single step with acetonitrile, ethyl acetate, and trifluoroacetic anhydride. As shown in Table I , of the four reaction temperatures tested for the TFA derivatization (40, 50, 60, and 808C), a temperature of 508C produced good results within a reaction time of up to 15 min. However, at reaction times of 15-40 min, a temperature of 408C produced better results than the other three temperatures (50, 60, and 808C). Therefore, TFA derivatization was performed for 40 min at 408C. The TFA derivatives produced were confirmed in the subsequent GC -MS analysis. 
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derivatized (1R, 2S)-(-)-EP (A), (1R, 2S)-(-)-NE (B), and IS (C). EP, ephedrine; NE, norephedrine; and IS, internal standard [(S)-(þ)-ethylamphetamine].
( Figure 1C ). The cleavage patterns of IS were similar to those of TFA-derivatized MA and amphetamine, which Kamei et al. (24) demonstrated by GC-MS analysis. Each parent ion (M þ ) of the m/z 357, 343, and 259 fragment ions of EP, NE, and IS were also barely detectable in EI mode.
Enantiomers of NE and EP and identification of their diastereomers Two fragment ions, m/z 140 for both the NE enantiomers [(1R, 2S)-( -) form (I) and (1S, 2R)-(þ) form (II)] and the PNE enantiomers [(1R, 2R)-( -) form (III) and (1S, 2S)-(þ) form (IV)]
, and m/z 154 for the EP and PEP enantiomers, were chosen as the target ions for identification and quantification by chiral capillary SIM GC -MS analysis (a JEOL mass spectrometer was used). At the same time, the relationships of the diastereomers were also clarified by the enantiomeric analysis of NE and PNE: the (I) and (IV) stereoisomers and the (II) and (III) stereoisomers, respectively, are also diastereomers. These relationships are also true of the EP and PEP enantiomers. The m/z 168 fragment was chosen as the target ion for IS. Figure 2A shows typical SIM chromatograms for the eight TFA stereoisomers in 0.2 mL of human plasma fortified with each pure racemate (125 ng/mL of EP, PEP, NE, or PNE in plasma). The retention times and fragment ions of each of the eight TFA stereoisomers were identical to those of the eight pure individual TFA stereoisomers. Each TFA stereoisomer of the four EP analogues (EP, NE, PEP, and PNE) and IS were simultaneously analyzed within 43 min, and it was also possible to identify the EP and NE enantiomers and diastereomers. However, an analysis faster than that presented here (analytical time, 43 min) was not possible because an analytical temperature limit of 2308C was required for the b-DEX 225 capillary column used in this analysis. Therefore, our chiral capillary SIM GC -MS method required a longer time (about three times longer) than the analytical time (about 15 min) required for the CE method of Miyatake et al. (7), but the sensitivity of our method was superior (about 200-to 600-fold) to that of the CE analysis (7) . Furthermore, only the separation of the EP enantiomers was defective under the conditions used for this analysis, compared with the separation of the NE, PEP, and PNE enantiomers (Figure 2A ). This defective separation is thought to be related to a diastereomer aggregate that formed between the stereoisomers and b-cyclodextrin (column phase). The background noise of the three fragment ions was very low, and two of the fragment ions (m/z 140 and 154) related to EP and the EP analogues were not detected in the control human plasma ( Figure 2B ). Therefore, the simultaneous identification of EP and the enantiomers and diastereomers of NE was achieved in one step, whereas the method of Shin et al. (16, 18) requires two separate analyses of both N-MTPA-O-TMS and N-MTPA-O-TEA derivatives.
Calibration curves, limits, and sample volumes The calibration curves constructed, based on the peak areas of each stereoisomer of EP, NE, PEP, and PNE versus IS using SIM GC -MS, were linear in the ranges of 12.5 -1250 ng/mL plasma for the EP enantiomers and 5.0 -1250 ng/mL plasma for the PEP, NE, and PNE enantiomers, with R 2 values of 0.9965 -0.9999 (Table II) . To construct this calibration curve, 0.2 mL of human plasma was used, and the analytes were reconstituted in 1 mL of ethyl acetate. This adjustment was made to mitigate the burden on the column phase of the traces of acylation reagent that remain in the reconstituted solution. Therefore, the analytes in the reconstituted solution were diluted fivefold relative to the analytes in the original plasma sample (0.2 mL). The actual limits of detection (LODs) and quantification (LOQs) obtained under these conditions were as described.
The LODs were 7.5 ng/mL plasma for the EP enantiomers and 2.5 ng/mL plasma for the PEP, NE, and PNE enantiomers, with a signal-to-noise ratio of 3 (Table II) . The LOQs were 12.5 ng/mL plasma for the EP enantiomers and 5 ng/mL plasma for the PEP, NE, and PNE enantiomers, with a signal-to-noise ratio of 10 (Table II) . The SIM chromatograms at the LODs are shown in Figure 3A . These LODs and LOQs were about the same for the guinea pig plasma. The LOD data produced with our chiral capillary SIM GC -MS method are superior to those produced with the CE methods of Miyatake et al. (7) and Chinaka et al. (26) , or with the CE-MS method of Iio et al. (17) . The LOD of Miyatake et al. (7) was 1,500 ng/mL for the EP and NE enantiomers and that of Chinaka et al. (26) was 100 ng/mL. The LOD of the CE -MS method of Iio et al (17) was 10 ng/mL for the EP enantiomers and 20 ng/mL for the NE enantiomers. In contrast to these methods, the EI SIM GC -MS assay using the chiral derivatization method of Shin et al. (16, 18) was more sensitive than our chiral capillary SIM GC -MS assay or the CE-MS assay (17) , with an LOD of less than 0.1 ng/mL for the EP and NE enantiomers. Therefore, the method of Shin et al. (16, 18 ) is superior to our method, but the sensitivity of our method can be improved (about sixfold) by dissolving the analytes in a small amount of solvent (e.g., 0.2 mL), as shown in Figure 3B . Nevertheless, the actual detection of the four EP analogues (in 0.2 mL of plasma) was adequate when 1.0 mL of solution reconstituted in ethyl acetate was used (see the Analyzing plasma samples section).
The method of Shin et al. (16, 18) has excellent sensitivity, as mentioned, but it requires 3 mL of urine for the analysis of the enantiomers and diastereomers of EP and NE. Furthermore, the applicability of this method, including the chiral derivatization of EP and NE, to blood or plasma samples has not been examined. Considering the limited sample volumes often available in forensic toxicology and pharmacokinetic studies, the greatest potential advantage of our method is its capacity to detect and identify the enantiomers and diastereomers of EP and NE in only 0.2 mL of plasma. This volume should also be sufficient for urine analysis.
Inter-and intraday precision and accuracy and recovery The validation data were calculated with five measurements of three different concentrations of the eight pure individual stereoisomer (25, 500, and 1250 ng/mL) of four EP analogues (EP, PEP, NE, and PNP) in human plasma samples. The intraday and interday precisions (% coefficients of variation) were less than 5.9% and 8.2%, respectively, and the accuracy data ranged from 94.7% to 107.8% for the intraday and 94.2% to 109.6% for the interday (Table III) . Based on these validation results, it appears that our method can determine the enantiomers and diastereomers of EP and NE with good reproducibility. Moreover, the average recoveries (n ¼ 3) of the eight stereoisomers from plasma samples spiked with three different concentrations of the eight pure individual stereoisomer (25, 500, and 1250 ng/mL in plasma) were in the range of 60.8 -64.5%. The relatively low recovery from plasma may be attributable to the effects of the plasma matrix (e.g., proteins and lipids).
Analyzing plasma samples
Human plasma. The validity of the chiral capillary SIM GC -MS method was confirmed by identifying the stereoisomers from two OTC cold medicines containing (1S, 2S)-(þ)-PEP or (1R, 2S)-(-)-EP in human plasma samples. In the plasma sample of subject 1, who was given a cold medicine containing (1S, 2S)-(þ)-PEP, only the stereoisomers of unchanged (1S, 2S)-(þ)-PEP and N-demethylated (1S, 2S)-(þ)-PNE were detected within 2 h ( Figure 4A ). According to Baba et al. (27) , the PNE detected is the main PEP metabolite identifiable in human urine. The two stereoisomers detected were configurations of the (1S, 2S)-(þ) form of the original PEP. The plasma levels of (1S, 2S)-(þ)-PEP and (1S, 2S)-(þ)-PNE were 34 and 64 ng/mL, respectively. Similarly, in the plasma sample of subject 2, who was given a cold medicine containing (1R, 2S)-(-)-EP, the only two stereoisomers detected within 2 h were unchanged (1R, 2S)-( -)-EP and N-demethylated (1R, 2S)-(-)-NE. The two stereoisomers detected were configurations of the (1R, 2S)-(-) form ( Figure 4B ). The plasma levels of EP and NE were 33 and 62 ng/mL, respectively.
Guinea pig plasma. The main EP metabolites found in the guinea pig urine are unchanged EP, N-demethylated NE, and para-hydroxylated compounds, according to Jacquot et al. (21) . Of these metabolites, we selected EP and NE as the targets for stereoisomer determination, and unchanged EP and N-demethylated NE were found in the plasma samples collected within 2 h of racemic EP administration. The two stereoisomers detected were the (1S, 2R)-(þ) and (1R, 2S)-( -) forms of EP and NE ( Figure 5A ), based on comparisons with two pure individual stereoisomers. The plasma levels of EP were 15 ng/mL for the (1S, 2R)-(þ) form and 21 ng/mL for the (1R, 2S)-( -) form. The plasma levels of NE were 25 ng/mL for the (1S, 2R)-(þ) form and 31 ng/mL for the (1R, 2S)-( -) form. In the control guinea pig plasma (Figure 5B ), the two fragment ions (m/z 140 and 154) related to unchanged EP and N-demethylated NE were not detected. These results indicate that the metabolic chiral inversion of EP and NE does not occur in the guinea pig, but that the stereoselective metabolism of the EP racemate occurred in the plasma.
